BRIEF-Medigene: patent for treatment of stem cell or bone-marrow transplanted patients – Reuters
|
BRIEF-Medigene: patent for treatment of stem cell or bone-marrow transplanted patients
Reuters Feb 23 Medigene AG : * Strengthens its DC platform with patent for treatment of stem cell or bone-marrow transplanted patients. * Announces grant of U.S. patent 9,238,063 by U.S. patent office (USPTO) covering semi-allogeneic anti-tumour vaccines with … |
